APA (7th ed.) Citation

A, B., D, H., A, E., S, Y., P, L., M, L., . . . P, E. (2002). Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer. Breast cancer research and treatment, 73(2), 161. https://doi.org/10.1023/a:1015229630260

Chicago Style (17th ed.) Citation

A, Buzdar, et al. "Phase III Randomized Trial of Droloxifene and Tamoxifen as First-line Endocrine Treatment of ER/PgR-positive Advanced Breast Cancer." Breast Cancer Research and Treatment 73, no. 2 (2002): 161. https://doi.org/10.1023/a:1015229630260.

MLA (9th ed.) Citation

A, Buzdar, et al. "Phase III Randomized Trial of Droloxifene and Tamoxifen as First-line Endocrine Treatment of ER/PgR-positive Advanced Breast Cancer." Breast Cancer Research and Treatment, vol. 73, no. 2, 2002, p. 161, https://doi.org/10.1023/a:1015229630260.